Tissue Necrosis Therapy

Stason Pharma gets world-wide non-exclusive license to use Lonza's GS Gene Expression System
Pharmabiz
Sat, 12/18/10 - 12:48 pm
Statson Pharma
Lonza
Tissue Necrosis Therapy
monoclonal antibodies